SPIROMETRY TESTING PROGRAM

Patients with chronic obstructive pulmonary disease (COPD), asthma, and other lung diseases are among the frequent users of the healthcare system. COPD accounted for 8 million trips to a doctor’s office or outpatient department in 2000. That same year, an estimated 10 million U.S. adults reported having physician-diagnosed COPD. In addition, the disease has emerged as the fourth leading cause of death in the United States for those over age 45. The estimated cost of treating COPD exceeds $23 billion each year.
Asthma, another common lung disease, was responsible for 10.4 million visits to physicians’ offices and hospital clinics in 2000. More than a third of the 24 million Americans who have asthma are children, making it the most common chronic childhood disease. The estimated annual cost of treating asthma, which results in nearly 5,000 deaths each year, is more than $8 billion.
Screening and monitoring treatment effectiveness is essential to properly manage patients with known or suspected lung disease. Clinical practice guidelines published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the National Institutes of Health recommend spirometry testing for patients suffering from COPD and Asthma.
Respiratory Care Consulting Services, Inc. (RCCS) can provide spirometry testing for pediatric and primary care practices as well as homebound patients.

Advantages of using Respiratory Care Consulting Services, Inc. Spiromerty program:

• No cost to practice.
• No additional staff needed.
• Free up time of present staff to provide patient care.
• Evaluate pulmonary status of homebound patients.
• Early detection of pulmonary disease.
• Tests performed by Licensed Respiratory Therapists.
• Equipment provided by Respiratory Care Consulting Services, Inc.
• RCCS will assist practice with Coding and Billing issues.

For more information regarding our Spirometry Program contact
Respiratory Care Consulting Services, Inc. at (615) 599-7278